Literature DB >> 23821260

In vitro kinetic profiling of hepatitis C virus NS3 protease inhibitors by progress curve analysis.

Rumin Zhang1, William T Windsor.   

Abstract

Kinetic profiling of drug binding to its target reveals important mechanistic parameters including drug-target residence time. In this chapter, we focus on global progress curve analysis as a convenient method for kinetic profiling. Detailed guidelines with pros and cons for various experimental designs and data analysis are provided. Kinetic profiling of Boceprevir and Telaprevir is illustrated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23821260     DOI: 10.1007/978-1-62703-484-5_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Pharmacodynamics: Which trails are your drugs taking?

Authors:  Rumin Zhang
Journal:  Nat Chem Biol       Date:  2015-04-20       Impact factor: 15.040

2.  Translating slow-binding inhibition kinetics into cellular and in vivo effects.

Authors:  Grant K Walkup; Zhiping You; Philip L Ross; Eleanor K H Allen; Fereidoon Daryaee; Michael R Hale; John O'Donnell; David E Ehmann; Virna J A Schuck; Ed T Buurman; Allison L Choy; Laurel Hajec; Kerry Murphy-Benenato; Valerie Marone; Sara A Patey; Lena A Grosser; Michele Johnstone; Stephen G Walker; Peter J Tonge; Stewart L Fisher
Journal:  Nat Chem Biol       Date:  2015-04-20       Impact factor: 15.040

3.  Drug design from the cryptic inhibitor envelope.

Authors:  Chul-Jin Lee; Xiaofei Liang; Qinglin Wu; Javaria Najeeb; Jinshi Zhao; Ramesh Gopalaswamy; Marie Titecat; Florent Sebbane; Nadine Lemaitre; Eric J Toone; Pei Zhou
Journal:  Nat Commun       Date:  2016-02-25       Impact factor: 14.919

4.  In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa.

Authors:  Katherine Young; Ronald E Painter; Susan L Raghoobar; Nichelle N Hairston; Fred Racine; Douglas Wisniewski; Carl J Balibar; Artjohn Villafania; Rumin Zhang; Daniel F Sahm; Timothy Blizzard; Nicholas Murgolo; Milton L Hammond; Mary R Motyl
Journal:  BMC Microbiol       Date:  2019-07-04       Impact factor: 3.605

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.